This company seems to have been delisted
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
Reason: Rebranded as Revvity
Last recorded trade on: July 18, 2023
Source: https://www.fiercebiotech.com/medtech/post-spinoff-perkinelmer-rebrands-diagnostics-life-sciences-business-revvity
PerkinElmer
PKI
C$156.76
Share price
-0.91%
Change (1 day)
-27.38%
Change (1 year)
Categories
PerkinElmer, Inc. is an American chemical and medical technology company with operations in environmental health and human health.
PerkinElmer (PKI) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : C$8.98 Billion
According to PerkinElmer 's latest financial reports the company's total liabilities are C$8.98 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
PerkinElmer - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | C$9.13 B | -9.07% |
| 2021-12-31 | C$10.04 B | 84.37% |
| 2020-12-31 | C$5.45 B | 11.86% |
| 2019-12-31 | C$4.87 B | 5.5% |
| 2018-12-31 | C$4.61 B | 2.37% |
| 2017-12-31 | C$4.51 B | 58.12% |
| 2016-12-31 | C$2.85 B | 1.38% |
| 2015-12-31 | C$2.81 B | 15.9% |
| 2014-12-31 | C$2.42 B | 16.7% |
| 2013-12-31 | C$2.08 B | 6.65% |
| 2012-12-31 | C$1.95 B | -3.98% |
| 2011-12-31 | C$2.03 B | 58.36% |
| 2010-12-31 | C$1.28 B | -15.04% |
| 2009-12-31 | C$1.51 B | -8.93% |
| 2008-12-31 | C$1.65 B | 20.97% |
| 2007-12-31 | C$1.37 B | 26.24% |
| 2006-12-31 | C$1.08 B | -10.58% |
| 2005-12-31 | C$1.21 B | -9.37% |
| 2004-12-31 | C$1.33 B | -17.95% |
| 2003-12-31 | C$1.63 B | -34.73% |
| 2002-12-31 | C$2.50 B | 0.95% |
| 2001-12-31 | C$2.47 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | C$67.41 B | 650.36% | 🇺🇸 USA |
 Waters Corporation WAT | C$3.57 B | -60.19% | 🇺🇸 USA |
 Agilent Technologies A | C$8.19 B | -8.82% | 🇺🇸 USA |
 Bruker BRKR | C$5.55 B | -38.19% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | C$3.87 B | -56.88% | 🇺🇸 USA |
 Becton Dickinson BDX | C$39.75 B | 342.53% | 🇺🇸 USA |
 Illumina ILMN | C$5.18 B | -42.25% | 🇺🇸 USA |